Reversal of an aluminium induced alteration in redox status in different regions of rat brain by administration of centrophenoxine
- 86 Downloads
Aluminium is one of the most studied neurotoxin, and its effects on nervous system are both structural and functional, involving various regions of brain. Aluminium toxicity is known to have multiple mechanisms of action in the central nervous system. Affinity of aluminium for thiol substrates is considered a possible molecular mechanism involved in aluminium neurotoxicity. The reduced glutathione (GSH) is especially important for cellular defence against aluminium toxicity. This study pertains to the modulatory action of Centrophenoxine on GSH status in aluminium exposed different brain regions of the female rats. Aluminium was administered orally at a dose of 40 mg/Kg. b.wt. /day for a period of eight weeks whereas, Centrophenoxine was administered intraperitoneally at a dose of 100 mg/Kg b.wt./day for a period of six weeks. The study was carried out in different regions of brain namely Cerebrum, Cerebellum, Medulla Oblongata and Hypothalamus. Animals exposed to aluminum, registered a significant decrease in the levels of reduced glutathione, and oxidized glutathione as well as in the activity of glutathione reductase in all the different regions studied when compared to normal control animals. Post-treatment with Centrophenoxine, showed a significant improvement in the thiol levels in different regions. Centrophenoxine when administered alone also had a profound effect on the levels of reduced glutathione as well as on the activity of glutathione reductase. From the present results, it can be stated that Centrophenoxine administration, as a thiol-antioxidant, arrests the aluminium induced cellular damage by improving the thiol status in brain regions.
Key wordsAluminium Centrophenoxine Glutathione Oxidative stress
Unable to display preview. Download preview PDF.
- 2.Kong S, Liochev S, Fridovh I: Aluminum (III) facilitates the oxidation of NADH by the superoxide anion. Free Radical Med Boil 13: 79, 1992Google Scholar
- 5.Vina, J, Vina JR: Role of gamma-glutamyltranspeptidase in the regulation of amino acid uptake by mammary gland of the lactating rat. In: A. Larsson, S. Orrenius, A. Holmgrem and B. Mannervik (eds). Functions of glutathione, biochemical, Physiological, Toxicological, and Clinical Aspects. Raven Press, New York, 1983, pp 23–30Google Scholar
- 7.Holmgren A: Glutathione dependent synthesis of deoxyribonucleotide. Purification and chanracterization of glutaredoxin from E. Coli J Biol Chem 254: 3664–3671, 1979Google Scholar
- 13.Zs-Nagy I: A survey of the available data on a new nootropic drugs, BCE-001. Ann NY Acad Sci 717: 102–14, 1994Google Scholar
- 18.Flaten, TP: Aluminum is a risk factor in Alzheimer disease, with emphasis on drinking water. Brain Research Bull 55(2): 152–167, 2001Google Scholar
- 19.Sinczuk – walezak, H: Nervous system disorders induced by occupational exposure to aluminium compounds: a literature review. Med Pr 52(6): 479–81, 2001Google Scholar
- 20.Condreicka R, Ginter E, Kortus J: Chronic toxicity of aluminium in rats and mice and its effects on phosphorous metabolism. Br J Ind Med 23: 305–312, 1996Google Scholar
- 21.Cherrot G, Desor D, Hutin MF, Burel D, Capoleghil B, Lehr PR: Effects of aluminium chloride on normal and uremic adult male rats: tissue distribution, brain choline, acetyl transferase activity and some biological variable. Biol Trace Element 54: 43–53, 1995Google Scholar
- 24.Aries I, Jakoby WB: Glutathione metabolism and functions. Kroc Found Ser C 1–382, 1976Google Scholar
- 25.Reed DJ, Fariss MW: Glutathione depletion and susceptibility. Pharmacol Rev 36: 525–533, 1984Google Scholar